Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1965 3
1966 1
1967 2
1968 1
1969 2
1979 1
1988 1
1989 1
1990 1
1993 1
1994 1
1996 3
1997 2
1998 2
1999 6
2000 3
2001 5
2002 7
2003 10
2004 5
2005 11
2006 17
2007 19
2008 20
2009 23
2010 24
2011 26
2012 12
2013 14
2014 28
2015 33
2016 37
2017 39
2018 45
2019 62
2020 51
2021 51
2022 61
2023 57
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

617 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Llobat
Page 1
Lola.
Sedehi N. Sedehi N. Acad Psychiatry. 2022 Aug;46(4):534. doi: 10.1007/s40596-022-01656-7. Epub 2022 Jun 3. Acad Psychiatry. 2022. PMID: 35661337 No abstract available.
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. Jain A, et al. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34822189 Clinical Trial.
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We evaluated the role of intravenous LOLA in patients of cirrhosis with OHE grade III-IV. ...LOLA was given as continuous intrave …
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We …
L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
Butterworth RF, McPhail MJW. Butterworth RF, et al. Drugs. 2019 Feb;79(Suppl 1):31-37. doi: 10.1007/s40265-018-1024-1. Drugs. 2019. PMID: 30706425 Free PMC article. Review.
This manuscript represents an appraisal of the evidence in support of L-ornithine-L-aspartate (LOLA) for the management and treatment of hepatic encephalopathy (HE) in cirrhosis. ...These findings provide support for the use of LOLA in the treatment of HE and future …
This manuscript represents an appraisal of the evidence in support of L-ornithine-L-aspartate (LOLA) for the management and treatment …
Management of Portal Hypertension.
Kulkarni AV, Rabiee A, Mohanty A. Kulkarni AV, et al. J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1184-1199. doi: 10.1016/j.jceh.2022.03.002. Epub 2022 Mar 21. J Clin Exp Hepatol. 2022. PMID: 35814519 Free PMC article. Review.
Functional characterization and proteomic analysis of lolA in Xanthomonas campestris pv. campestris.
Liao CT, Chiang YC, Hsiao YM. Liao CT, et al. BMC Microbiol. 2019 Jan 21;19(1):20. doi: 10.1186/s12866-019-1387-9. BMC Microbiol. 2019. PMID: 30665348 Free PMC article.
These phenotypic changes of the mutant could be complemented to the wild-type level through the intact lolA gene. Proteomic analysis revealed that 109 proteins were differentially expressed after lolA mutation. ...Furthermore, the results of this study provide and e …
These phenotypic changes of the mutant could be complemented to the wild-type level through the intact lolA gene. Proteomic analysis …
Physical Rehabilitation for Small Animals.
Gamble LJ. Gamble LJ. Vet Clin North Am Small Anim Pract. 2022 Jul;52(4):997-1019. doi: 10.1016/j.cvsm.2022.03.005. Epub 2022 May 11. Vet Clin North Am Small Anim Pract. 2022. PMID: 35562217 Review.
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.
Kircheis G, Lüth S. Kircheis G, et al. Drugs. 2019 Feb;79(Suppl 1):23-29. doi: 10.1007/s40265-018-1023-2. Drugs. 2019. PMID: 30706424 Free PMC article. Review.
L-Ornithine L-aspartate (LOLA), a stable salt of L-ornithine and L-aspartate, readily dissociates into its constituent amino acids that are readily absorbed by active transport, distributed, and metabolized. ...These metabolic pathways were elucidated based upon studies in …
L-Ornithine L-aspartate (LOLA), a stable salt of L-ornithine and L-aspartate, readily dissociates into its constituent amino acids th …
Nephrology from a gender perspective.
Arenas Jiménez MD, Martin-Gómez MA, Carrero JJ, Ruiz Cantero MT. Arenas Jiménez MD, et al. Nefrologia (Engl Ed). 2018 Sep-Oct;38(5):463-465. doi: 10.1016/j.nefro.2018.04.001. Epub 2018 May 24. Nefrologia (Engl Ed). 2018. PMID: 29803293 Free article. English, Spanish. No abstract available.
Lola regulates Drosophila adult midgut homeostasis via non-canonical hippo signaling.
Hao X, Wang S, Lu Y, Yu W, Li P, Jiang D, Guo T, Li M, Li J, Xu J, Wu W, Ho MS, Zhang L. Hao X, et al. Elife. 2020 Jan 14;9:e47542. doi: 10.7554/eLife.47542. Elife. 2020. PMID: 31934851 Free PMC article.
Not only that Lola interacts with and is stabilized by the Hippo signaling core kinase Warts (Wts), Lola rescues the enhanced ISC proliferation upon Wts depletion via suppressing Dref and SkpA expressions. Our findings reveal that Lola is a non-canonical Hipp …
Not only that Lola interacts with and is stabilized by the Hippo signaling core kinase Warts (Wts), Lola rescues the enhanced …
617 results